Results 161 to 170 of about 30,575 (221)

Vamorolone Safety, Pharmacokinetics, and Exploratory Efficacy in Duchenne Muscular Dystrophy: A Phase II, Nonrandomized, Multiple-Dose Study in 2-<4-Year-Old Boys. [PDF]

Neurology
Mah JK, Gonorazky HD, Nigro E, Lochmüller H, Alemán A, Yaworski A, Oskoui M, Sbrocchi AM, Selby KA, de Vera A, Mathur R, Gresko E, Linden A, Dutreix C, Hoffman EP.   +14 more
europepmc   +1 more source

The miR-30c-5p/SOCS3 axis is a potential driver of inflammation and metabolic imbalance in Duchenne muscular dystrophy. [PDF]

Front Cell Dev Biol
Wang Y, Ai X, Chang Y, Zhang S, Zhang P, Wu S.   +5 more
europepmc   +1 more source

Long-read sequencing identifies complex structural variants in DMD patients. [PDF]

BMC Med Genomics
Xie Y, Bao L, Yu X, Liu Y.
europepmc   +1 more source

Targeting autophagy in Duchenne muscular dystrophy: mechanistic insights and emerging therapeutic strategies. [PDF]

J Med Genet
Krishna L, Srivathsa A, Anand R, Rao A, Karnik M, Vishwanath P, Dharmashekar C, Kumar Honnavalli Y, Prashant A.   +8 more
europepmc   +1 more source

Generation of an induced pluripotent stem cell line (NCHi026-A) from a patient with a partial deletion of exon 55 in the DMD gene. [PDF]

Stem Cell Res
Lin H, Nicolau S, Stevens K, Vetter TA, Atkins S, Frair EC, Wein N, Zhao MT, Gushchina LV, Flanigan KM.   +9 more
europepmc   +1 more source

Potential benefits of Ayurveda in Duchenne muscular Dystrophy: A case based analysis. [PDF]

J Ayurveda Integr Med
Puja MS, Jyothy KB, Kulkarni V, Srihari S.   +3 more
europepmc   +1 more source